Figures & data
Figure 1 When an antigen (Ag) is presented in the context of the major histocompatibility complex (MHC) to the T cell receptor (TCR), binding of B7 with CD28 occurs which activates the T cell. Slightly later, the activated T cell stimulates CTLA4 which also binds to B7 to down-regulate the T cell. Ipilimumab inactivates the binding of CTLA4 with B7, allowing the T cell to remain activated.
Abbreviations: Ag, antigen; MHC, major histocompatibility complex; TCR, T cell receptor.
![Figure 1 When an antigen (Ag) is presented in the context of the major histocompatibility complex (MHC) to the T cell receptor (TCR), binding of B7 with CD28 occurs which activates the T cell. Slightly later, the activated T cell stimulates CTLA4 which also binds to B7 to down-regulate the T cell. Ipilimumab inactivates the binding of CTLA4 with B7, allowing the T cell to remain activated.Abbreviations: Ag, antigen; MHC, major histocompatibility complex; TCR, T cell receptor.](/cms/asset/4550d5b7-c9f0-45c8-b4df-3344ead8727d/dcmr_a_15551_f0001_b.jpg)
Table 1 Treatment outcome with diarrhea
Table 2 Immunosuppressive guidelines
Table 3 Doses of immunosuppressive agents